New quinolone
You're interested in learning about new quinolones!
Quinolones are a class of antibiotics that have been widely used to treat bacterial infections. In recent years, there has been a growing concern about the emergence of quinolone-resistant bacteria, which has led to the development of new quinolones with improved properties.
Here are some recent developments in the field of quinolones:
- Ciprofloxacin (Cipro): This is a well-known quinolone antibiotic that has been widely used to treat bacterial infections. In 2020, a new formulation of ciprofloxacin was approved by the FDA, which is designed to be more effective against resistant bacteria.
- Moxifloxacin (Avelox): This is another widely used quinolone antibiotic that has been shown to be effective against a range of bacterial infections. In 2019, a new formulation of moxifloxacin was approved by the FDA, which is designed to be more effective against resistant bacteria.
- Pefloxacin (Pfizer): This is a new quinolone antibiotic that has been developed by Pfizer. It has been shown to be effective against a range of bacterial infections, including those caused by resistant bacteria.
- Ceftobiprole (Zevtera): This is a new quinolone antibiotic that has been developed by Basilea Pharmaceutica. It has been shown to be effective against a range of bacterial infections, including those caused by resistant bacteria.
- NXL104 (Nabriva Therapeutics): This is a new quinolone antibiotic that has been developed by Nabriva Therapeutics. It has been shown to be effective against a range of bacterial infections, including those caused by resistant bacteria.
These are just a few examples of the many new quinolones that are being developed. Quinolones are an important class of antibiotics, and continued research and development are necessary to ensure that we have effective treatments for bacterial infections.
Would you like to know more about the mechanism of action of quinolones or their potential side effects?